ATE327769T1 - Silica enthaltende pastenformulierungen - Google Patents

Silica enthaltende pastenformulierungen

Info

Publication number
ATE327769T1
ATE327769T1 AT01905731T AT01905731T ATE327769T1 AT E327769 T1 ATE327769 T1 AT E327769T1 AT 01905731 T AT01905731 T AT 01905731T AT 01905731 T AT01905731 T AT 01905731T AT E327769 T1 ATE327769 T1 AT E327769T1
Authority
AT
Austria
Prior art keywords
formulations containing
containing silica
paste formulations
paste
silica
Prior art date
Application number
AT01905731T
Other languages
English (en)
Inventor
Chen Jun
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Application granted granted Critical
Publication of ATE327769T1 publication Critical patent/ATE327769T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01905731T 2000-02-16 2001-02-05 Silica enthaltende pastenformulierungen ATE327769T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/504,741 US6787342B2 (en) 2000-02-16 2000-02-16 Paste formulations

Publications (1)

Publication Number Publication Date
ATE327769T1 true ATE327769T1 (de) 2006-06-15

Family

ID=24007536

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01905731T ATE327769T1 (de) 2000-02-16 2001-02-05 Silica enthaltende pastenformulierungen
AT06005716T ATE430583T1 (de) 2000-02-16 2001-02-05 Pastenformulierungen enthaltend silica

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06005716T ATE430583T1 (de) 2000-02-16 2001-02-05 Pastenformulierungen enthaltend silica

Country Status (20)

Country Link
US (1) US6787342B2 (de)
EP (2) EP1263467B1 (de)
JP (1) JP2003522805A (de)
AR (1) AR029655A1 (de)
AT (2) ATE327769T1 (de)
AU (2) AU3373801A (de)
BR (1) BRPI0108449B8 (de)
CA (1) CA2400317C (de)
CY (2) CY1105626T1 (de)
CZ (1) CZ304469B6 (de)
DE (2) DE60138660D1 (de)
DK (2) DK1688149T3 (de)
ES (2) ES2326426T3 (de)
HK (1) HK1094321A1 (de)
NZ (2) NZ532434A (de)
PL (1) PL203304B1 (de)
PT (2) PT1688149E (de)
RU (2) RU2304962C2 (de)
WO (1) WO2001060409A1 (de)
ZA (1) ZA200206484B (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429320B1 (en) * 2000-08-04 2002-08-06 Cognis Corporation Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures
CA2430816C (en) * 2000-12-07 2012-05-15 Altana Pharma Ag Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US7943160B2 (en) 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
PL1610613T3 (pl) 2003-04-04 2017-06-30 Merial, Inc. Miejscowe preparaty weterynaryjne przeciw robakom
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US7671034B2 (en) * 2003-12-19 2010-03-02 Merial Limited Stabilized formulation of ivermectin feed premix with an extended shelf life
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
WO2006099390A1 (en) * 2005-03-14 2006-09-21 Macrochem Corporation Enhancement of macrolide penetration through human skin
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
PL2035390T3 (pl) 2006-07-05 2016-06-30 Merial Inc Związki będące pochodnymi 1-arylo-5-alkilopirazolu, sposoby ich wytwarzania i zastosowania
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
CA2673193C (en) * 2006-12-19 2014-08-05 Merial Limited Homogeneous paste and gel formulations
SI3088384T1 (sl) 2007-05-15 2019-04-30 Merial, Inc. Ariloazol-2-il cianoetilamino spojine, postopek njihove izdelave in njihova uporaba
CA2718966A1 (en) * 2008-03-20 2009-09-24 Lynn Chambers Anti-inflammatory drug delivery system
US9820977B2 (en) * 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
EP2364301B1 (de) 2008-11-14 2015-09-02 Merial Limited Enantiomerenangereicherte parasitizide aryloazol-2-yl-cyanoethylaminoverbindungen
WO2010059529A2 (en) 2008-11-19 2010-05-27 Merial Limited Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
NZ593184A (en) 2008-12-04 2012-11-30 Merial Ltd Dimeric avermectin and milbemycin derivatives
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
CA2769385C (en) 2009-07-30 2017-10-17 Merial Limited Insecticidal 4-amino-thieno[2,3-d]-pyrimidine compounds and methods of their use
US8846569B2 (en) 2009-12-04 2014-09-30 Merial Limited Pesticidal bis-organosulfur compounds
DK3078664T3 (da) 2009-12-17 2019-05-13 Merial Inc Antiparasitiske dihydroazol-sammensætninger
AU2010330844B2 (en) 2009-12-17 2014-11-27 Boehringer Ingelheim Animal Health USA Inc. Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
CA2818563C (en) 2010-11-16 2019-11-12 Merial Limited Monensin derivatives for the treatment and prevention of protozoal infections.
WO2013003505A1 (en) 2011-06-27 2013-01-03 Merial Limited Amido-pyridyl ether compounds and compositions and their use against parasites
US20120329832A1 (en) 2011-06-27 2012-12-27 Jean Delaveau Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use
WO2013053755A2 (en) * 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
CN104023720B (zh) 2011-11-17 2016-10-26 梅里亚有限公司 包含芳基吡唑和取代咪唑的组合物，其方法和用途
MX358476B (es) 2011-12-02 2018-08-22 Merial Ltd Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.
AP2014007874A0 (en) 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
AU2015261543C1 (en) * 2012-02-27 2022-10-13 Elanco New Zealand Controlled release compositions and their methods of use
US10828311B2 (en) * 2012-02-27 2020-11-10 Bayer New Zealand Limited Controlled release compositions and their methods of use
RU2646483C2 (ru) 2012-04-04 2018-03-05 Интервет Интернэшнл Б.В. Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений
RU2486905C1 (ru) * 2012-05-28 2013-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") Средство для лечения мастита у животных
RU2512683C2 (ru) * 2012-06-08 2014-04-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Антибактериальная инъекционная фармацевтическая композиция
US20180042953A1 (en) * 2012-06-08 2018-02-15 Obshchestvo S Ogranichennoy Otvetstvennostyu "Vik - Zdorovye Zhivotnykh" Antibacterial injectable pharmaceutical composition
NZ708350A (en) 2012-11-20 2016-08-26 Merial Inc Anthelmintic compounds and compositions and method of using thereof
US20150238654A1 (en) * 2012-12-18 2015-08-27 Gregory J. Pomrink Irrigation resistant compositions for regeneration of hard tissues and methods and kits of using the same
EP3063144B1 (de) 2013-11-01 2021-09-08 Boehringer Ingelheim Animal Health USA Inc. Antiparasitäre und pestizide isoxazolinverbindungen
CN106536518B (zh) 2014-05-19 2020-05-12 勃林格殷格翰动物保健美国公司 驱蠕虫化合物
HUE055535T2 (hu) 2015-05-20 2021-12-28 Boehringer Ingelheim Animal Health Usa Inc Féreghajtó depszipeptid-vegyületek
KR101614814B1 (ko) 2015-11-13 2016-04-22 바이엘코리아주식회사 집먼지진드기 구제 조성물
WO2017121740A1 (en) 2016-01-15 2017-07-20 Basf Se Conductive paste
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
JP2019535655A (ja) 2016-10-14 2019-12-12 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 殺虫性及び殺寄生虫性ビニルイソオキサゾリン化合物
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
BR112019013612B1 (pt) 2017-01-31 2022-08-09 Kimberly-Clark Worldwide, Inc Método para inibir o crescimento bacteriano em um produto, composição antibacteriana, e, lenço.
EP3381479A1 (de) * 2017-03-29 2018-10-03 ARTOSS GmbH Trägerzusammensetzung für knochenersatzmaterialien
EP3668866B1 (de) 2017-08-14 2023-01-18 Boehringer Ingelheim Animal Health USA Inc. Pestizide und parasitizide pyrazolisoxazolinverbindungen
WO2019157241A1 (en) 2018-02-08 2019-08-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
AU2019301510B2 (en) 2018-07-09 2024-06-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
US11560388B2 (en) 2019-03-19 2023-01-24 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic aza-benzothiophene and aza-benzofuran compounds
CN111387179B (zh) * 2020-04-29 2021-11-12 河北威远生物化工有限公司 一种阿维菌素B2a溶剂化固体及其制备方法
WO2021242581A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2562830A (en) 1951-07-31 Derivatives
US11637A (en) 1854-09-05 Flour-bolt
US537195A (en) 1895-04-09 Conduit electric railway
US3337570A (en) 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof
US4009197A (en) 1967-01-13 1977-02-22 Syntex Corporation 2-(6-Substituted-2'-naphthyl) acetic acid derivatives and the salts and esters thereof
US3904682A (en) 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
BE792990A (fr) * 1971-12-23 1973-06-19 Shell Int Research Procede de lutte contre les endoparasites chez les chevaux
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3896145A (en) 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
CH604517A5 (de) 1976-08-19 1978-09-15 Ciba Geigy Ag
US5089490A (en) 1977-04-02 1992-02-18 Hoechst Aktiengesellschaft Cephem derivatives
GB2006492B (en) 1977-08-12 1982-01-20 English Electric Co Ltd Input circuits
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4465663A (en) 1981-07-27 1984-08-14 Basf Wyandotte Corporation Polyoxybutylene-polyoxyethylene aqueous gels
US4343785A (en) 1981-08-10 1982-08-10 Basf Wyandotte Corporation Gel dentifrice compositions
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
US4476107A (en) 1983-06-13 1984-10-09 Basf Wyandotte Corporation Mouthwash composition
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
DE3340680A1 (de) 1983-11-10 1985-05-23 Henkel Kgaa Verfahren zur erhoehung der viskositaet von oelen
US4686092A (en) 1984-04-13 1987-08-11 Union Carbide Corporation Manganese-aluminum-phosphorus-silicon-oxide molecular sieves
IL76708A (en) 1984-10-18 1990-01-18 Ciba Geigy Ag Substituted n-benzoyl-n'-(2,5-dichloro-4(1,1,2,3,3,3-hexafluoropropyloxy)-phenyl)ureas,their preparation and pesticidal compositions containing them
US4781920A (en) 1984-11-13 1988-11-01 American Cyanamid Company Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
EP0192060B1 (de) 1985-02-04 1991-09-18 Nihon Bayer Agrochem K.K. Heterocyclische Verbindungen
US4562936A (en) * 1985-02-12 1986-01-07 The Procter & Gamble Company Easy-open laminated container with optional reclosing means and method of making
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
GB8713768D0 (en) 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
DE3767560D1 (de) 1986-03-25 1991-02-28 Sankyo Co Makrolide verbindungen, ihre herstellung und verwendung.
EP0252879B1 (de) 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4758435A (en) 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (de) 1987-11-03 1994-04-06 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung
US4891211A (en) 1988-06-29 1990-01-02 Church & Dwight Co., Inc. Stable hydrogen peroxide-releasing dentifice
US5215890A (en) 1988-11-03 1993-06-01 Spyros Theodoropulos Chromogenic substrate to peroxidase enzymes
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5288496A (en) 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
CA2036148A1 (en) 1990-06-29 1991-12-30 Hiroki Tomioka A 1-phenylimidazole derivative and its production and use
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5072716A (en) 1990-07-30 1991-12-17 Toxoric, Inc. Archery bow sighting device
US5122377A (en) 1990-11-19 1992-06-16 A.H. Robins, Company, Incorporated Oral delivery system for veterinary drugs
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
DE69204942T2 (de) * 1991-08-19 1996-02-08 Weissenfluh Hawe Neos Zahnputzmittel.
AU658681B2 (en) * 1991-10-23 1995-04-27 Block Drug Company Inc., The Penetration enhancement of topically applied formulations
US5288469A (en) 1992-03-16 1994-02-22 Envirosurgical, Inc. Surgery plume filter device
IS3990A (is) 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
US5210235A (en) 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
GB9602877D0 (en) * 1996-02-13 1996-04-10 Merck Frosst Canada Inc 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
HRP931480B1 (en) 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
JP3715994B2 (ja) 1993-12-21 2005-11-16 住友化学株式会社 害虫防除剤
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
SK284840B6 (sk) 1995-03-20 2005-12-01 Merck & Co., Inc. Deriváty kyseliny nodulisporovej a farmaceutický prostriedok s ich obsahom
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US5981576A (en) * 1995-10-13 1999-11-09 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
US6020343A (en) * 1995-10-13 2000-02-01 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
US5880076A (en) * 1997-08-04 1999-03-09 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycacarbamate and glycaurea compounds
US5888523A (en) * 1997-09-22 1999-03-30 Biocontrol, Inc. Topical non-steroidal anti-inflammatory drug composition
IL129102A0 (en) 1999-03-22 2000-02-17 J P M E D Ltd An emulsion

Also Published As

Publication number Publication date
DE60138660D1 (de) 2009-06-18
CZ304469B6 (cs) 2014-05-21
US20030007958A1 (en) 2003-01-09
EP1263467A1 (de) 2002-12-11
EP1688149B1 (de) 2009-05-06
BRPI0108449B8 (pt) 2021-05-25
RU2304962C2 (ru) 2007-08-27
DK1688149T3 (da) 2009-06-29
HK1094321A1 (en) 2007-03-30
BR0108449A (pt) 2003-04-01
CZ20022772A3 (cs) 2003-01-15
WO2001060409A1 (en) 2001-08-23
DE60120122D1 (de) 2006-07-06
CA2400317C (en) 2009-04-21
RU2452468C2 (ru) 2012-06-10
PT1263467E (pt) 2006-08-31
AU2001233738B2 (en) 2005-11-03
BRPI0108449B1 (pt) 2018-02-27
EP1688149B9 (de) 2009-09-09
AR029655A1 (es) 2003-07-10
JP2003522805A (ja) 2003-07-29
EP1263467B1 (de) 2006-05-31
ES2266157T3 (es) 2007-03-01
RU2007120070A (ru) 2008-12-10
NZ520707A (en) 2004-07-30
ZA200206484B (en) 2003-10-16
CA2400317A1 (en) 2001-08-23
CY1109286T1 (el) 2014-07-02
AU3373801A (en) 2001-08-27
ATE430583T1 (de) 2009-05-15
ES2326426T3 (es) 2009-10-09
PL356429A1 (en) 2004-06-28
DE60120122T2 (de) 2006-09-21
RU2002124584A (ru) 2004-03-10
PL203304B1 (pl) 2009-09-30
EP1688149A1 (de) 2006-08-09
PT1688149E (pt) 2009-07-31
DK1263467T3 (da) 2006-10-02
NZ532434A (en) 2005-09-30
CY1105626T1 (el) 2010-12-22
US6787342B2 (en) 2004-09-07

Similar Documents

Publication Publication Date Title
ATE327769T1 (de) Silica enthaltende pastenformulierungen
EE200200387A (et) Fulvestrandi formulatsioonid
DK1317177T3 (da) Desinficerende formuleringer
ATE303787T1 (de) Schergelzusammensetzungen
DE60129705D1 (de) Monoalkylglycerinäther stabile zusammensetzungen
AR028291A1 (es) Formulaciones oftalmicas
DE69805443T2 (de) Sachet-formulierungen
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20026175L (no) Vaksinesammensetning
NO20004240D0 (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
AR028197A1 (es) Composiciones antitranspirantes
PT1130966E (pt) Formulacoes antiparasitarias
ATE263487T1 (de) Flüssige formulierungen
DE60131992D1 (de) Pfropfcopolymere enthaltende klebstoffe
ATE369830T1 (de) Schweisshemmende zusammensetzungen
IS6398A (is) Lyfjablöndur
ATE314049T1 (de) Schweisshemmende zusammensetzungen
EP1329224A4 (de) Über lange zeit stabilisierte lösungen
DE60102050D1 (de) Glaszusammensetzung
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
GB0015490D0 (en) Novel formulations
DE60116858D1 (de) Zusammensetzung
ATE268116T1 (de) Mesotrion-formulierungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1263467

Country of ref document: EP